This announcement is a separate document:
JIG-SAW株式会社：Jig−SAWは再生医学分野でソフトウェアに基づく細胞制御技術(プロジェクト新視覚技術)の米国特許承認を得た
JIG-SAW Inc: JIG-SAW receives U.S. patent approval for software-based cell control technology (The project NEW-VISION technology) in field of regenerative medicine
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.